P53 Expression in Oropharyngeal Squamous Cell Carcinoma
is Increased in HPV Positive Smokers
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BACKGROUND & OBJECTIVES
High risk HPV is associated with oropharyngeal SCC (OSCC) and is responsible
for the increasing incidence of this cancer type among younger patients.
Patients with HPV positive oropharyngeal SCC have a better prognosis when
compared with HPV negative, tobacco induced SCC.
HPV E6 inactivates p53 leading to low expression of p53; tobacco induced
oropharyngeal SCC is characterized by p53 overexpression, resistance to
treatment and poor prognosis. However, in many cases of HPV OSCC, there is
a history of current or remote smoking, making this disease a multifactorial
process. We expect that smoking will influence the level of p53 expression in
HPV positive smokers.

Figure 1: Immunohistochemistry stain for p53 in OSCC
(high expression), 200x

Figure 2: Immunohistochemistry stain for p53 in OSCC
(low expression), 200x

Figure 3: Positive immunohistochemistry stain for
p16 in OSCC, 200x

Figure 4: Negative immunohistochemistry stain for
p16 in OSCC, 200x

The objective of our study is to evaluate the differences in p53 expression in
HPV positive and HPV negative patients, smokers and nonsmokers.

DESIGN
Retrospective study that included 101 cases of OSCC, 65 p16 positive and 36 p16
negative patients. In each group patients have been divided in nonsmokers,
smokers and patients with remote smoking history (quit smoking at least 3 years prior
to diagnosis).
IHC stain for p53 was performed in all cases. Low expression was defined as staining
in less than 20% of tumor cell nuclei. High expression was defined as staining in
more than 20% of tumor cell nuclei.

RESULTS
P16 positive and p16 negative patients demonstrated significantly different p53 profile.
Low p53 expression was noted in the vast majority of p16 positive patients. P16
negative patients, especially current and remote smokers, demonstrated the highest
percentage of high p53 expression.
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CONCLUSION
Our study demonstrates that the majority of patients with HPV positive OSCC show
a low p53 staining, in agreement with the known effect of viral E6 protein on cell
cycle. Among the p16 positive patients, current smokers demonstrated the highest
percentage of p53 overexpression.
In the p16 negative group, the highest level of p53 expression was in smokers (current
and remote smoking history).
Our study brings strong evidence that p53 is increased in p16/HPV positive patients
who are active smokers. The level of p53 expression is intermediary between p16
positive nonsmokers and p16 negative smokers. This difference may contribute to
the previously described negative effect that smoking has on response to treatment
and prognosis in HPV positive smokers.
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